bpc 157 fda compounding category BPC-157 Legal Status: Regulations and FDA Peptide Update: Category 2
FDA Peptide Update: Category 2 Removals Explained HIMS jumps more than 7% after an FDA panel recommends adding BPC 157 to the 503A compounding list potentially opening a new peptide category. The opportunity fits Hims existing telehealth, compounding and customer FDA Adds Several Peptides to Category 2 Bulks List, Restricting Them From Compounding Restore Health Consulting FDA panel backs compounded BPC 157, KPV peptides in win for RFK Jr. STAT
Pay in 4 interest-free payments of $6.82 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7


